AwardedPOLGoods
Sukcesywne dostawy leku Fruzaqla do programu lekowego B.4 dla SPZOZ Opolskie Centrum Onkologii w Opolu
- Published
- Published 10 June 2026
Overview
Successive deliveries of the drug Fruzaqla for pharmaceutical program B.4 to the Opole Oncology Center, with specific product types and quantities as detailed in the procurement documentation. The contract was awarded to Takeda Pharma Sp. z o.o. on 2 June 2026 for a value of 1,389,066.4 PLN.
Key details
- Country
- POL
- Status
- Awarded
- Category
- Goods
- Procedure
- Direct
- Published
- 10 June 2026
Pharmaceutical products
Award outcome
- Awarded value
- PLN 1,389,066
- Award date
- 2 June 2026
- Contract period
- 19 June 2026 → 14 June 2027
- Takeda Pharma Sp. z o.o.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
7 July 2026
Contract Notice
10 June 2026
Contracting authority
Samodzielny Publiczny Zakład Opieki Zdrowotnej Opolskie Centrum Onkologii im. prof. Tadeusza Koszarowskiego w Opolu
Procuring entityOpole, POL
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.